#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA3540344	ADME	Drug level in Sprague-Dawley rat plasma assessed as compound formation treated with [14C]brivanib alaninate at 100 mg/kg, po administered as single dose via gavage measured after 1 hr by HPLC analysis	Rattus norvegicus	10	ALA3526109	organism-based format	Scientific Literature
2.	ALA3540345	ADME	Drug level in Sprague-Dawley rat plasma assessed as compound formation treated with [14C]brivanib alaninate at 100 mg/kg, po administered as single dose via gavage measured after 2 hrs by HPLC analysis	Rattus norvegicus	10	ALA3526109	organism-based format	Scientific Literature
3.	ALA3540346	ADME	Drug level in Sprague-Dawley rat plasma assessed as compound formation treated with [14C]brivanib alaninate at 100 mg/kg, po administered as single dose via gavage measured after 6 hrs by HPLC analysis	Rattus norvegicus	10	ALA3526109	organism-based format	Scientific Literature
4.	ALA3540350	ADME	Drug level in cynomolgus monkey plasma assessed as compound formation treated with [14C]brivanib alaninate at 10 mg/kg, po administered as single dose via gavage measured after 6 hrs by HPLC analysis	Macaca fascicularis	11	ALA3526109	organism-based format	Scientific Literature
5.	ALA3540351	ADME	Drug level in cynomolgus monkey plasma assessed as compound formation treated with [14C]brivanib alaninate at 10 mg/kg, po administered as single dose via gavage measured after 12 hrs by HPLC analysis	Macaca fascicularis	11	ALA3526109	organism-based format	Scientific Literature
6.	ALA3540352	ADME	Drug level in human plasma assessed as compound formation treated with [14C]brivanib alaninate at 800 mg, po administered as single dose via gavage measured after 1 hr by HPLC analysis	Homo sapiens	11	ALA3526109	organism-based format	Scientific Literature
7.	ALA3540353	ADME	Drug level in human plasma assessed as compound formation treated with [14C]brivanib alaninate at 800 mg, po administered as single dose via gavage measured after 2 hrs by HPLC analysis	Homo sapiens	11	ALA3526109	organism-based format	Scientific Literature
8.	ALA3538179	ADME	Drug level in human plasma assessed as compound formation treated with [14C]brivanib alaninate at 800 mg, po administered as single dose via gavage measured after 4 hrs by HPLC analysis	Homo sapiens	11	ALA3526109	organism-based format	Scientific Literature
9.	ALA3538180	ADME	Drug level in human plasma assessed as compound formation treated with [14C]brivanib alaninate at 800 mg, po administered as single dose via gavage measured after 8 hrs by HPLC analysis	Homo sapiens	11	ALA3526109	organism-based format	Scientific Literature
10.	ALA3538181	ADME	Drug level in human plasma assessed as compound formation treated with [14C]brivanib alaninate at 800 mg, po administered as single dose via gavage measured after 12 hrs by HPLC analysis	Homo sapiens	11	ALA3526109	organism-based format	Scientific Literature
11.	ALA3538195	ADME	Drug level in human liver microsomes treated with brivanib by LC-MS/MS analysis in presence of NADPH	Homo sapiens	1	ALA3526109	assay format	Scientific Literature
12.	ALA3538196	Binding	Inhibition of human recombinant VEGFR-2	Homo sapiens	4	ALA3526109	single protein format	Scientific Literature
13.	ALA3538197	Binding	Inhibition of human recombinant FGFR-1	Homo sapiens	4	ALA3526109	single protein format	Scientific Literature
14.	ALA3538438	ADME	Drug level in cynomolgus monkey plasma assessed as compound formation treated with [14C]brivanib alaninate at 10 mg/kg, po administered as single dose via gavage measured after 1 hr by mass spectrometry	Macaca fascicularis	2	ALA3526109	organism-based format	Scientific Literature
15.	ALA3538439	ADME	Drug level in cynomolgus monkey plasma assessed as compound formation treated with [14C]brivanib alaninate at 10 mg/kg, po administered as single dose via gavage measured after 2 hrs by mass spectrometry	Macaca fascicularis	2	ALA3526109	organism-based format	Scientific Literature
16.	ALA3538440	ADME	Drug level in cynomolgus monkey plasma assessed as compound formation treated with [14C]brivanib alaninate at 10 mg/kg, po administered as single dose via gavage measured after 4 hrs by mass spectrometry	Macaca fascicularis	2	ALA3526109	organism-based format	Scientific Literature
17.	ALA3531846	ADME	Activity of human CYP2D6 assessed as compound formation treated with 2 and 20 uM brivanib for 20 mins by LC/MS analysis in presence of NADPH	Homo sapiens	1	ALA3526086	single protein format	Scientific Literature
18.	ALA3531847	ADME	Activity of human CYP3A5 assessed as compound formation treated with 2 and 20 uM brivanib for 20 mins by LC/MS analysis in presence of NADPH	Homo sapiens	1	ALA3526086	single protein format	Scientific Literature
19.	ALA3531848	ADME	Activity of human CYP2C19 assessed as compound formation treated with 2 and 20 uM brivanib for 20 mins by LC/MS analysis in presence of NADPH	Homo sapiens	1	ALA3526086	single protein format	Scientific Literature
20.	ALA3531849	ADME	Activity of human CYP2C8 assessed as compound formation treated with 2 and 20 uM brivanib for 20 mins by LC/MS analysis in presence of NADPH	Homo sapiens	1	ALA3526086	single protein format	Scientific Literature